Generics Bulletin is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sandoz Will Differentiate To Serve A Different World

Executive Summary

A differentiated offering that includes biosimilars, value-added medicines and digital health technologies is central to Sandoz’ mission to improve both patient health and its own profit margins, according to CEO Richard Francis.
Advertisement

Related Content

Beximco Expands In US With Eight ANDAs From Sandoz
Sandoz Sets Forth On Quest To Raise Its Margins
Sandoz Phases US Epinephrine Entry
Transformed Sandoz Is Important Part Of Novartis
Novartis ‘committed’ to Sandoz
Aurobindo snaps up US businesses from Sandoz

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

GB139924

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel